WO2025124486 - GLP-1 RECEPTOR COMPOUNDS, PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry:
Publication Number
WO/2025/124486
Publication Date
19.06.2025
International Application No.
PCT/CN2024/138845
International Filing Date
12.12.2024
Title **
[English]
GLP-1 RECEPTOR COMPOUNDS, PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
COMPOSÉS DE RÉCEPTEUR GLP-1, LEUR PROCÉDÉ DE PRÉPARATION ET LEUR UTILISATION
[Chinese]
一种GLP-1受体化合物及其制备方法与应用
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
SHANDONG SALUBRIS PHARMACEUTICALS CO., LTD.
Inventors
XU, Wenjie
LIAN, Xiaolei
XING, Wei
ZHANG, Shu
XIAO, Ying
CAO, Dapeng
ZHU, Ruihua
HUA, Huaijie
LI, Qinze
Priority Data
202311734636.4
15.12.2023
CN
202311735337.2
15.12.2023
CN
202410327937.3
20.03.2024
CN
202410325171.5
20.03.2024
CN
202410658027.3
24.05.2024
CN
202410678168.1
28.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1931 | |
| EPO | Filing, Examination, Granting | 11666 | |
| Japan | Filing, Examination, Granting | 2080 | |
| South Korea | Filing, Examination, Granting | 2082 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,499
Contact Us
Abstract[English]
The present application relates to the technical field of therapeutic peptides, and relates to compounds represented by general formula (I), or racemates thereof, or isomers thereof, or pharmaceutically acceptable salts thereof, as GLP-1 compounds, and the use thereof in treating diseases.[French]
La présente invention concerne le domaine technique des peptides thérapeutiques, et concerne des composés représentés par la formule générale (I), ou des racémiques, des isomères, ou des sels pharmaceutiquement acceptables de ceux-ci, en tant que composés de GLP-1, et leur utilisation pour traiter des maladies.[Chinese]
本申请属于治疗性肽技术领域，涉及一种通式(I)所示的化合物，或其消旋体、或其异构体、或其可药用的盐，作为GLP-1化合物，以及使用其治疗疾病的用途。